BG Medicine (BGMD) Reports Higher Incidents of Heart Failure in Recent Galectin-3 Study
Tweet Send to a Friend
BG Medicine, Inc. (Nasdaq: BGMD), announced that the study, "Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
